Search Within

Ashwin Kishtagari

Formats
  1. Meeting Abstract (11)
  2. Journal Article (4)
Groups
  1. Adult Leukemia (13)
  2. Center for Hematologic Malignancies (13)
  3. Department of Medicine (13)
  4. Hematologic Malignancies, Division of (13)
  5. Biostatistics Service (10)
  6. Epidemiology and Biostatistics (10)

More Groups

People
  1. Martin Tallman (12)
  2. Sean Devlin (10)
  3. Eytan Stein (6)
  4. Maria Arcila (6)
  5. Ross Levine (6)
  6. Ahmet Zehir (4)

More People

Years
  1. 2017 (1)
  2. 2016 (3)
  3. 2015 (3)
  4. 2014 (3)
  5. 2013 (5)
Publications
  1. Blood (7)
  2. Acta Haematologica (1)
  3. Biology of Blood and Marrow Transplantation (1)
  4. British Journal of Haematology (1)
  5. Cell Stem Cell (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. Elsevier Inc. (1)
  5. Elsevier Ltd (1)
  6. John Wiley & Sons (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes
    Journal Article

    Coombs, C. C.; Zehir, A.; Devlin, S. M.; Kishtagari, A.; Syed, A.; Jonsson, P.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; more...
    Cell Stem Cell (2017)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis in patients with advanced cancer
    Meeting Abstract

    Zehir, A.; Coombs, C. C.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; Arcila, M. E.; Tallman, M. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Mutational analysis of clonal hematopoiesis in solid tumor patients illustrates the critical role of systemic anti-cancer therapies in the evolution of somatic leukemia disease alleles
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; Arcila, M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia
    Journal Article

    Watts, J. M.; Dumitriu, B.; Hilden, P.; Kishtagari, A.; Rapaport, F.; Chen, C.; Ahn, J.; Devlin, S. M.; Stein, E. M.; Rampal, R.; more...
    Leukemia Research (2016)

    Fulltext@MSK | Save
  • Herpes zoster is more frequent in patients receiving higher cumulative doses of arsenic trioxide and is mitigated by prophylactic acyclovir
    Meeting Abstract

    Glass, J. L.; Kishtagari, A.; Douer, D.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Next-generation sequencing of matched normal blood identifies clonal hematopoiesis in a significant subset of solid tumor patients without hematologic malignancies
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Middha, S.; Cheng, D.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Melanoma and non-melanoma skin cancers in hairy cell leukaemia: A Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center
    Journal Article

    Watts, J. M.; Kishtagari, A.; Hsu, M.; Lacouture, M. E.; Postow, M. A.; Park, J. H.; Stein, E. M.; Teruya-Feldstein, J.; Abdel-Wahab, O.; Devlin, S. M.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Telomere length is associated with specific mutations and mutation classes in patients with acute myeloid leukemia
    Meeting Abstract

    Watts, J. M.; Dumitriu, B.; Hilden, P.; Chen, C.; Rapaport, F.; Kishtagari, A.; Ahn, J.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Survivorship in adolescents and young adults
    Journal Article

    Kishtagari, A.; Tavakkoli, M.; Park, J. H.
    Acta Haematologica (2014)

    Fulltext@MSK | Save
  • Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?
    Meeting Abstract

    Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save